Cargando…
Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer
Clinical evidence indicates that drug resistance is a great obstacle in breast cancer therapy. It renders the disease uncontrollable and causes high mortality. Multiple mechanisms contribute to the development of drug resistance, but the underlying cause is usually a shift in the genetic composition...
Autores principales: | Chen, Yinnan, Zhang, Yanmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010891/ https://www.ncbi.nlm.nih.gov/pubmed/29938175 http://dx.doi.org/10.1002/advs.201700964 |
Ejemplares similares
-
The Application of the CRISPR-Cas System in Antibiotic Resistance
por: Tao, Shuan, et al.
Publicado: (2022) -
Application of CRISPR-Cas9 System to Study Biological Barriers to Drug Delivery
por: He, Ji, et al.
Publicado: (2022) -
CRISPR/Cas9 system: recent applications in immuno-oncology and cancer immunotherapy
por: Chen, Chen, et al.
Publicado: (2023) -
Application of CRISPR/Cas9 Technology to HBV
por: Lin, Guigao, et al.
Publicado: (2015) -
Application of CRISPR/Cas9 for biomedical discoveries
por: Riordan, Sean M., et al.
Publicado: (2015)